IL41 |
IL2[22-58] |
IL1 suppressor factor |
||
This term (Stremska et al, 2017) refers to a hybrid recombinant cytokine combining the activities of IL2 and IL33. The authors have reported that a major subset of regulatory T-cells in mice express the IL33 receptor ST2, and coinjection of IL2 and IL33 increased the number of these cells in lymphoid organs and protects mice from ischemia-reperfusion injury more efficiently than either cytokine alone. IL233 treatment increases the number of regulatory T-cells in blood and spleen and prevents ischemia-reperfusion injury more efficiently than a mixture of IL2 and
...
...
...
...
... Subscribe to continue reading!
... ...
Content view restricted ! |